Cancer Research and Treatment10.4143/crt.2018.48620195131231-1240Alterations in PD-L1 Expression Associated with Acquisition of Resistance to ALK Inhibitors in ALK-Rearranged Lung CancerSu-Jung Kim, Soyeon Kim, Dong-Wan Kim, Miso Kim, Bhumsuk Keam, Tae Min Kim, Yusoo Lee, Jaemoon Koh, Yoon Kyung Jeon, Dae Seog Heo,,
Lung Cancer10.1016/j.lungcan.2016.10.012201610238-41Histological transformation of ALK rearranged adenocarcinoma into small cell lung cancer: A new mechanism of resistance to ALK inhibitorsDelphine Levacq, Nicky D’Haene, Roland de Wind, Myriam Remmelink, Thierry Berghmans,
Therapeutic Strategies to Overcome ALK Resistance in Cancer10.1016/b978-0-12-821774-0.00013-9202131-53ALK rearranged lung cancer: TKI treatment and outcomeAna Collazo-Lorduy, Beatriz Jiménez, María Castro-Henriques, Jordi Remon,
Lung Cancer10.1016/j.lungcan.2020.04.011202014457-63Efficacy and safety of ALK inhibitors in ALK-rearranged non-small cell lung cancer: A systematic review and meta-analysisDaniel Breadner, Phillip Blanchette, Sumugan Shanmuganathan, Ronald Gabriel Boldt, Jacques Raphael,
Lung Cancer10.1016/j.lungcan.2020.12.022202115294-97Strong ALK and PD-L1 positive IHC expression related ALK amplification in an advanced lung sarcomatoid carcinoma: A therapeutic trap?Sébastien Gendarme, Lise Matton, Martine Antoine, Khaldoun Kerrou, Anne-Marie Ruppert, Christelle Epaud, Jacques Cadranel, Vincent Fallet,
Cancer Genetics10.1016/j.cancergen.2021.03.0062021256-25748-50Identification of a novel resistance ALK p.(Q1188_L1190del) deletion in a patient with ALK-rearranged non–small-cell lung cancerMoushumi Suryavanshi, Krushna Chaudhari, Shrinidhi Nathany, Vineet Talwar,
Lung Cancer10.1016/j.lungcan.2014.04.0132014852335-336Overcoming crizotinib resistance in ALK-rearranged non-small cell lung cancerXiaolong Qi, Wang Ma, Sen Li, Caicun Zhou,
OncoTargets and Therapy10.2147/ott.s1128332016Volume 96059-6063A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case reportJumpei Kashima, Yusuke Okuma, Tsunekazu Hishima,
Thoracic Cancer10.1111/1759-7714.127782018981078-1081ALK -rearranged lung cancer with intradural extramedullary spinal cord metastases responding to ceritinib treatment: A case reportYan Xu, Wei Zhong, Minjiang Chen, Jing Zhao, Mengzhao Wang,
Journal of Thoracic Oncology10.1016/j.jtho.2017.09.96120171211S2012-S2013P1.07-042 PD-L1 and CD8 Expression in EGFR-Mutant or ALK-Rearranged Patients with Lung CancerS. Liu, Z. Dong, S. Wu, Z. Xie, J. Su, J.-. Yang, X. Yang, Y. Wu,